Cotización Johnson and Johnson - JNJ

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

20.26

Postura de Compra

20.11

Postura de Venta

20.45

Volume Operado de la Acción

3,626

20.16 Rango del Día 20.29

0.00 Rango de 52 semanas 0.00

Precio Anterior

20.27

Precio de Apertura

20.20

Hora

20.19

Última hora de negociación

Volumen promedio (3 m)

Volumen financiero

Precio Promedio Ponderado

Findings from pivotal nipocalimab Phase 3 study in a broad antibody positive population of people living with generalized myasthenia gravis (gMG) published in The Lancet Neurology

Findings from pivotal nipocalimab Phase 3 study in a broad antibody positive population of people living with generalized myasthenia gravis (gMG) published in The Lancet Neurology PR...

Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Johnson & Johnson Reports Q4 and Full-Year 2024 Results

2024 Fourth-Quarter reported sales growth of 5.3% to $22.5 Billion with operational growth of 6.7%* and adjusted operational growth of 5.7%* 2024 Fourth-Quarter Earnings per share (EPS) of $1.41...

SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression

SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression PR Newswire TITUSVILLE, N.J., Jan. 21, 2025 Following U.S. FDA...

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer PR...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

JNJ - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Johnson and Johnson?

El precio actual de las acciones de Johnson and Johnson es $ 20.26

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Johnson and Johnson?

Johnson and Johnson ha negociado en un rango de $ 0.00 a $ 0.00 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
JETGlobal Crossing Airlines Group Inc	$ 1.06 (17.78%)	59.9k
CBSTCannabist Company Holdings Inc	$ 0.09 (12.50%)	263.98k
JET.BGlobal Crossing Airlines Group Inc	$ 1.00 (6.38%)	22.73k
MLCMount Logan Capital Inc	$ 3.00 (5.26%)	300
SUNNSolarBank Corporation	$ 4.02 (2.55%)	21.87k
LITSLithos Energy Ltd	$ 0.025 (-28.57%)	287k
HOLDImmutable Holdings Inc	$ 0.15 (-16.67%)	64.67k
GRAMGold Flora Corporation	$ 0.105 (-16.00%)	132.7k
BMNDBiomind Labs Inc	$ 0.285 (-10.94%)	670
IFSSInterfield Global Software Inc	$ 0.045 (-10.00%)	1,000
ALGOLight AI Inc	1.16 (-0.85%)	734.53k
DEFIValour Inc	$ 4.55 (-1.30%)	724.43k
GLAS.A.UGlass House Brands Inc	US$ 5.54 (-9.62%)	419.72k
VERSVerses AI Inc	$ 1.39 (-5.44%)	383.64k
LITSLithos Energy Ltd	$ 0.025 (-28.57%)	287k